Previous Close | 63.15 |
Open | 63.62 |
Bid | 63.51 x 900 |
Ask | 67.10 x 1100 |
Day's Range | 63.31 - 65.53 |
52 Week Range | 46.80 - 73.97 |
Volume | |
Avg. Volume | 1,506,186 |
Market Cap | 10.254B |
Beta (5Y Monthly) | 1.17 |
PE Ratio (TTM) | 53.98 |
EPS (TTM) | 1.21 |
Earnings Date | Apr 23, 2024 - Apr 29, 2024 |
Forward Dividend & Yield | 3.92 (6.00%) |
Ex-Dividend Date | Mar 27, 2024 |
1y Target Est | 71.50 |
Subscribe to Yahoo Finance Plus to view Fair Value for BXP
Boston Properties' (BXP) latest stake sale helps it capitalize on the value that investors are placing on well-positioned, well-managed and well-leased premier workplaces.
BOSTON, March 25, 2024--BXP (NYSE: BXP), the largest publicly traded developer, owner, and manager of premier workplaces in the United States, today announced that it has completed the previously announced sale of a 45% interest in 290 Binney Street, a life sciences development located in Kendall Square in Cambridge, Massachusetts, to Norges Bank Investment Management. NBIM’s investment will reduce BXP’s share of the project’s estimated development spend over time by approximately $533.5 million
Commercial real estate is in dire straits. Skeptics don’t have to look further than “The Monthly Dividend Company,” Realty Income (NYSE:O), a perennial favorite among income and REIT investors for proof. Shares in the top commercial real estate stock are down more than 11% since Jan. 1st with limited upside in sight. The reasons run the gamut you’re no doubt familiar with — higher rates, work-from-home permanency, sluggish consumer sentiment and more. But Realty Income isn’t the only commercial